Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2017: 3.556

CiteScore 2017: 2.34

SCImago Journal Rank (SJR) 2017: 1.114
Source Normalized Impact per Paper (SNIP) 2017: 1.188

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 56, Issue 6

Issues

Detection of autoantibodies to the p200-epitope of SSA/Ro52 antigen. A comparison of two laboratory assays

Elena Mattia / Ariela Hoxha / Marta Tonello / Maria Favaro / Teresa Del Ross / Antonia Calligaro / Anna Ghirardello / Amelia Ruffatti
Published Online: 2018-01-05 | DOI: https://doi.org/10.1515/cclm-2017-0704

Abstract

Background:

Anti-p200 antibodies have been receiving growing interest in view of findings associating their presence to risk of fetal autoimmune congenital heart block (CHB). The study compares and evaluates the performance of two assays currently being used for their detection.

Methods:

One hundred and sixteen pregnant women positive for anti-SSA/Ro52 antibodies were considered as the study population. Fifty women negative for anti-SSA/Ro52 antibodies were considered as the control population. Anti-p200 antibodies were analyzed using two home-made ELISA assays: one with biotinylated antigen and the other with free antigen.

Results:

The specificity of the p200-free assay was significantly higher with respect to that of the p200-biotin assay (p=0.023). Both methods showed a high area under curve (AUC), thus, a good accuracy. There was a significant prevalence of anti-p200 antibodies when the p200-free assay was used to analyze the sera of the pregnant women with CHB fetuses (p=0.007). Cohen’s κ and Spearman’s ρ coefficients showed a good concordance (0.71) and a high correlation (0.93), respectively.

Conclusions:

The p200-free assay with respect to the biotin-based method was more specific in detecting p200 antibodies in women positive for anti-SSA/Ro52 antibodies. In addition, only the p200-free method significantly found p200 antibodies in patients with fetal CHB.

This article offers supplementary material which is provided at the end of the article.

Keywords: anti-p200 antibodies; anti-SSA/Ro52 antibodies; congenital heart block; enzyme-linked immunosorbent assay

References

  • 1.

    Schulte-Pelkum J, Fritzler M, Mahler M. Latest update on the Ro/SSA autoantibody system. Autoimmun Rev 2009;8:632–7.CrossrefGoogle Scholar

  • 2.

    Brito-Zerón P, Izmirly PM, Ramos-Casals M, Buyon JP, Khamashta MA. The clinical spectrum of autoimmune congenital heart block. Nat Rev Rheumatol 2015;11:301–12.Web of ScienceCrossrefPubMedGoogle Scholar

  • 3.

    Dörner T, Trebeljahr G, Goldner B, Yamamoto K, Apostoloff E, Hiepe F. Detection of autoantibodies to Ro(SS-A), La(SS-B) and U1RNP in different congenital heart rhythm disorders using immunoblot and enzyme immunoassay. J Autoimmun 1994;7:93–106.CrossrefPubMedGoogle Scholar

  • 4.

    Brucato A, Cimaz R, Caporali R, Ramoni V, Buyon J. Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies. Clin Rev Allergy Immunol 2011;40:27–41.PubMedWeb of ScienceCrossrefGoogle Scholar

  • 5.

    Friedman DM, Rupel A, Buyon JP. Epidemiology, etiology, detection, and treatment of autoantibody associated congenital heart block in neonatal lupus. Curr Rheumatol Rep 2007;9:101–8.PubMedCrossrefGoogle Scholar

  • 6.

    Sonesson SE, Salomonsson S, Jacobsson LA, Bremme K, Wahren-Herlenius M. Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro52-kd antibodies. Arthritis Rheum 2004;50:1253–61.CrossrefGoogle Scholar

  • 7.

    Salomonsson S, Dörner T, Theander E, Bremme K, Larsson P, Wahren-Herlenius M. A serologic marker for fetal risk of congenital heart block. Arthritis Rheum 2002;46:1233–41.PubMedCrossrefGoogle Scholar

  • 8.

    Eftekhari P, Sallé L, Lezoualc’h F, Mialet J, Gastineau M, Briand JP, et al. Anti-SSA/Ro52 autoantibodies blocking the cardiac 5HT4 serotoninergic receptor could explain neonatal lupus congenital heart block. Eur J Immunol 2000;30:2782–90.CrossrefGoogle Scholar

  • 9.

    Fritsch C, Hoebeke J, Dali H, Ricchiuti V, Isenberg DA, Meyer O, et al. 52-kDa Ro/SSA epitopes preferentially recognized by antibodies from mothers of children with neonatal lupus and congenital heart block. Arthritis Res Ther 2006;8:R4.PubMedGoogle Scholar

  • 10.

    Strandberg L, Winqvist O, Sonesson SE, Mohseni S, Salomonsson S, Bremme K, et al. Antibodies to amino acid 200–239 (p200) of Ro52 as serological markers for the risk of developing congenital heart block. Clin Exp Immunol 2008;154:30–7.CrossrefWeb of SciencePubMedGoogle Scholar

  • 11.

    Reed, JH, Clancy RM, Lee KH, Saxena A, Izmirly PM, Buyon JP. Umbilical cord blood levels of maternal antibodies reactive with p200 and full-length Ro52 in the assessment of risk for cardiac manifestations of neonatal lupus. Arthritis Care Res 2012;64:1373–81.CrossrefGoogle Scholar

  • 12.

    Ambrosi A, Dzikaite V, Park J, Strandberg L, Kuchroo VK, Herlenius E, et al. Anti-Ro52 monoclonal antibodies specific for amino acid 200–239, but not other Ro52 epitopes, induce congenital heart block in a rat model. Ann Rheum Dis 2012;71:448–54.Web of ScienceCrossrefGoogle Scholar

  • 13.

    Landschulz WH, Johnson PF, McKnight SL. The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science 1988;240:1759–64.PubMedCrossrefGoogle Scholar

  • 14.

    Chan EK, Hamel JC, Buyon JP, Tan EM. Molecular definition and sequence motifs of the 52-kD component of human SS-A/Ro autoantigen. J Clin Invest 1991;87:68–76.CrossrefPubMedGoogle Scholar

  • 15.

    Alber T. Structure of the leucine zipper. Curr Opin Genet Dev 1992;2:205–10.PubMedCrossrefGoogle Scholar

  • 16.

    Salomonsson S, Sonesson SE, Ottosson L, Muhallab S, Olsson T, Sunnerhagen M, et al. Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block. J Exp Med 2005;201:11–7.CrossrefPubMedGoogle Scholar

  • 17.

    Tonello M, Ruffatti A, Favaro M, Tison T, Del Ross T, Calligaro A, et al. Maternal autoantibody profiles at risk for autoimmune congenital heart block: a prospective study in high-risk patients. Lupus Sci Med 2016;3:e000129.PubMedCrossrefGoogle Scholar

  • 18.

    Ruffatti A, Cerutti A, Favaro M, Del Ross T, Calligaro A, Hoxha A, et al. Plasmapheresis, intravenous immunoglobulins and bethametasone – a combined protocol to treat autoimmune congenital heart block: a prospective cohort study. Clin Exp Rheumatol 2016;34:706–13.PubMedGoogle Scholar

  • 19.

    Klauninger R, Skog A, Horvath L, Winqvist O, Edner A, Bremme K, et al. Serologic follow-up of children born to mothers with Ro/SSA autoantibodies. Lupus 2009;18:792–8.Web of SciencePubMedCrossrefGoogle Scholar

About the article

Corresponding author: Prof. Amelia Ruffatti, Rheumatology Unit, Department of Medicine-DIMED, University of Padua, Via Giustiniani 2, 35128 Padua, Italy, Phone: +39 049 8212192, Fax: +39 049 8212191


Received: 2017-08-09

Accepted: 2017-11-22

Published Online: 2018-01-05

Published in Print: 2018-05-24


Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), Volume 56, Issue 6, Pages 927–932, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2017-0704.

Export Citation

©2018 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Supplementary Article Materials

Comments (0)

Please log in or register to comment.
Log in